Market Overview
The global Nanodisc Membrane Scaffold Proteins (MSPs) market was valued at USD 202 million in 2024 and is projected to reach USD 303 million by 2031, exhibiting a CAGR of 6.1% during the forecast period.
Membrane scaffold proteins (MSPs) are specialized proteins used to reconstitute isolated membrane proteins within nanodiscs, providing a native-like lipid bilayer environment. These proteins are crucial for structural and functional studies of membrane proteins, including G protein-coupled receptors (GPCRs) and ion channels. The versatility of MSPs allows researchers to study membrane proteins in a stable, soluble form, facilitating applications in drug discovery, structural biology, and biophysical research.
USD 303 million by 2031 USD 202 million in 2024
of 6.1%
Unlabeled MSPs Segment Dominates the Market Due to Widespread Use in Structural Biology and Protein Reconstitution Studies
The market is segmented based on type into:
Labeled Unlabeled
By Application
The
Infectious
Drug
Others
https://www.24lifesciences.com
Our Key Players
Cube Biotech
Creative Biostructure
Merck KGaA
ACROBiosystems
